Philip Morris
Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
Fields
- Characteristic
- MISS, MISSING PAGES
- Type
- PSCI, PUBLICATION SCIENTIFIC
- Site
- N403
- Litigation
- Stmn/Produced
- Author (Organization)
- American Psychiatric Assn
- Master ID
- 2046398862/0490
Related Documents:- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
- Request
- Stmn/R1-036
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R4-005
- Stmn/R1-072
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- coj75e00
Document Images
DIAGNOSTIC AND SwisiicAL
MANUAL OF
MENTAL D1SORDE16
(THIRD EDITION - REVISED)
DSW
s
.a
-4
Published by the
American Psychiatric Association
Washington, DC
1987
Ii1A

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
150
OrQanic mernai Svndromes and Disorders
Diagnostic criteria for 305.90 Inhalant Intoxication continued -
(4) slurred speech
(5) unsteady gait
(6) lethargy
(7) depressed reflexes
(8) psychomotor retardation
(9) tremor
(10) generalized muscle weakness
(11) blurred vision or diplopia
(12) stupor or coma
(13) euphoria
D. Not due to any physical or other mental disorder.
Note: When the differential diagnosis must be made without a clear-cut history or
toxicologic analysis of body fluids, it may be qualified as "Provisional."
NICOTINE-INDUCED ORGANIC MENTAL DISORDER
292.00 Nicotine Withdrawal
See p. 181 for a description of the different forms of nicotine and Nicotine Depen-
dence.
The essential feature of this disorder is a characteristic withdrawal syndrome due to
the abrupt cessation of or reduction in the use of nicotine-containing substances (e.g.,
cigarettes, cigars, and pipes, chewing tobacco, or nicotine gum) that has been at least
moderate in duration and amount. The syndrome includes craving for nicotine; irritabil-
ity, frustration, or anger; anxiety; difficulty concentrating; restlessness; decreased heart
rate; and increased appetite or weight gain.
In many heavy cigarette-smokers, changes in mood and performance that are
related to withdrawal can be detected within two hours after the last tobacco use. The
sense of craving appears to reach a peak within the first 24 hours after cessation of
tobacco use, and gradually declines thereafter over a few days to several weeks. In any
given case it is difficult to distinguish a withdrawal effect from the emergence of
psychological traits that were suppressed, controlled, or altered by the effects of nico-
tine or from a behavioral reaction (e.g., frustration) to the loss of a reinforcer.
Mild symptoms of withdrawal may occur after switching to low tar/nicotine ciga-
rettes and after stopping the use of smokeless (chewing) tobacco or nicotine gum.
Associated features. Increased slow rhythms on an EEG, decreased catechol-
amines, decreased metabolic rate, tremor, increased coughing, REM change, gastroin-
testinal disturbance, headaches, insomnia, and impairment of performance on tasks
requiring vigilance are commonly associated features of Nicotine Withdrawal.
Course. The symptoms begin within 24 hours of cessation of or reduction in
nicotine use and usually decrease in intensity over a period of a few days to several
weeks. Some former nicotine users report that craving for the substance continues for
longer periods.

Opioid Intoxication 151
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Complications. Whether severe Nicotine Withdrawal decreases the ability to stop
smoking or remain abstinent from smoking is unknown.
Differential diagnosis. The diagnosis of Nicotine Withdrawal is usually self-evident
from the person's history, and disappearance of the symptoms if smoking is resumed is
confirmatory. However, withdrawal from other psychoactive substances may take
place simultaneously, and produce similar symptoms.
Diagnostic criteria for 292.00 Nicotine Withdrawal
A. Daily use of nicotine for at least several weeks.
B. Abrupt cessation of nicotine use, or reduction in the amount of nicotine used,
followed within 24 hours by at least four of the following signs:
(1) craving for nicotine
(2) irritability, frustration, or anger
(3) anxiety
(4) difficulty concentrating
(5) restlessness
(6) decreased heart rate
(7) increased appetite or weight gain
OPIOID-INDUCED ORGANIC MENTAL DISORDERS
See p. 182 for a description of substances in this class and Opioid Dependence and
Abuse.
305.50 Opioid Intoxication
The essential features of this disorder are mafadaptive behavioral changes and specific
neurologic signs due to the recent use of an opioid.
The initial maladaptive behavioral changes from intravenous opioids occur within
2 to 5 minutes after use and often include euphoria that may last 10 to 30 minutes. This
is followed by a longer period (two to six hours, depending upon the type of opioid, the
dose, and the previous history of drug-taking) of lethargy, somnolence, and apathy or
dysphoria. Other maladaptive behavioral effects during the period of intoxication
include impaired judgment and impaired social and occupational functioning. Unlike
in Alcohol Intoxication, aggression and violence are rare.
Pupillary constriction is always present (or dilation due to anoxia from a severe
overdose). Other neurologic signs commonly observed are drowsiness, slurred speech,
and impairment in attention and memory.
Associated features. Pupillary constriction may lead to reduced visual acuity. The
inhibitory effect of the psychoactive substance on gastrointestinal motility may cause
constipation. There may be analgesia.
For many people, the effect of taking an opioid for the first time is dysphoric rather
than euphoric, and nausea and vomiting may result.
I

I
I
I
I.:.scription of Inhalant
g, through the mouth
ices such as gasoline,
~ are the halogenated
pray-can propellants
I ycols. These volatile
ts, and may be used
?nce. There may be
iifferent compounds,
, iish among them. All
!!/ substances that can
ices, it is difficult to
~ ss there is clear evi-
eral term "inhalant"
I
I
I
I
I
I
I
I
I
:e patterns resulting
1-acting vasodilators
0 Psychoactive Sub-
cating vapors. Most
th and nose and the
ar or plastic bag, and
-tly from containers,
orts of using heating
lungs, bloodstream,
d with varying con-
le concentrations in
considerable family
hoactive Substance
ency, truancy, poor
icidence of inhalant
is, although depen-
~conomic groups.
ed to age. Inhalants
rally with a group of
it use may increase
, and the peer group
j young adults who
ibstances as adoles-
s have become the
idence in industrial
)mpounds. In these
for its psychoactive
dence.
Nicotine Dependence 181
Associated features. Users of inhalants nearly always use other psychoactive sub-
stances as well. When Inhalant Dependence exists, however, it is usually clear that
inhalants are the preferred substance, and inhalants are used regularly whereas other
substances are used only sporadically. Even occasional users of inhalants are likely to
have significant physical and mental problems.
Course. Younger children diagnosed as having Inhalant Dependence may use
inhalants several times a week, often on weekends and after school. Severe depen-
dence in young adults may involve varying periods of intoxication throughout each day
and occasional periods of heavier use that may last several days. This pattern may
persist for many years, with recurrent need for treatment. Users of inhalants may have a
preferred level or degree of intoxication, and the method of administration allows a
user to maintain that specific level for several hours. Chronic heavy users of inhalants
may develop renal and hepatic complications.
Tolerance to inhalants has been reported, but may be merely increased use over
time, with more periods of intoxication and increased preference for higher levels of
intoxication. Withdrawal has also been reported, but there is inadequate evidence to
substantiate its existence.
Prevalence. No information.
305.10 Nicotine Dependence
See Nicotine-Induced Organic Mental Disorders (p. 150) for a description of Nicotine
Withdrawal.
Patterns of use. At present, the most common form of Nicotine Dependence is
associated with the inhalation of cigarette smoke. Pipe- and cigar-smoking, the use of
snuff, and the chewing of tobacco are less likely to lead to Nicotine Dependence. The
more rapid onset of nicotine effects with cigarette-smoking leads to a more intensive
habit pattern that is more difficult to give up because of the frequency of reinforcement
and the greater physical dependence on nicotine.
Associated features. People with this disorder are often distressed because of their
inability to stop nicotine use, particularly when they have serious physical symptoms
that are aggravated by nicotine. Some people who have Nicotine Dependence may
have difficulty remaining in social or occupational situations in which smoking is pro-
hibited.
Course. The course of Nicotine Dependence is variable. Most people repeatedly
.attempt to give up nicotine use without success. In some the dependence is brief, in
that when they experience concern about nicotine use, they promptly make an effort
to stop smoking and are successful, though in many cases they may experience a
period of Nicotine Withdrawal lasting from days to weeks. Studies of treatment out-
come suggest that the relapse rate is greater than 50% in the first 6 months, and at least
.70% within the first 12 months. After a year's abstinence, subsequent relapse is un-
tikely.
'f, The difficulty in giving up nicotine use definitively, particularly cigarettes, may be
due to the unple;.sant nature of the withdrawal syndrome, the deeply engrained nature
,of -the habit, the repeated effects of nicotine, which rapidly follow the inhalation of
cigarette smoke (75,000 puffs per year for a pack-a-day smoker), and the likelihood that
,a desire to use nicotine is elicited by environmental cues, such as the ubiquitous

182 Psychoactive Substance Use Disorder;
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
presence of other smokers and the widespread availability of cigarettes. When efforts
to give up smoking are made, Nicotine Withdrawal may develop.
Impairment. Since nicotine, unlike alcohol, rarely causes any clinically significant
state of intoxication, there is no impairment in social or occupational functioning as an
immediate and direct consequence of its use.
Complications. The most common complications are bronchitis, emphysema, cor-
onary artery disease, peripheral vascular disease, and a variety of cancers.
Prevalence and sex ratio. A large proportion of the adult population of the United
States has Nicotine Dependence, the prevalence among males being greater than that
among females. Among teen-age smokers, males are affected approximately as often as
females.
Familial pattern. Cigarette smoking among first-degree biologic relatives of people
with Nicotine Dependence is more common than among the general population.
Evidence for a genetic factor has been documented, but the effect is modest.
304.00 Opioid Dependence
305.50 Opioid Abuse
See Opioid-induced Organic Mental Disorders (p. 151) for a description of Opioid
Intoxication and Withdrawal.
This group includes natural opioids, such as heroin and morphine, and synthetics
with morphinelike action, which act on opiate receptors. These compounds are pre-
scribed as analgesics, anesthetics, or cough-suppressants. They include codeine,
hydromorphone, meperidine, methadone, oxycodone, and others. Several other com-
pounds that have both direct opiatelike agonist effects and antagonist effects are
included in this class of substances because they often produce the same physiologic
and behavioral effects as pure opioids, e.g., pentazocine and buprenorphine. Prescrip-
tion opiates are typically taken orally in pill form, but can also be taken intravenously;
heroin is typically taken intravenously, but can also be taken by nasal inhalation or
smoking. Regular use of these substances leads to remarkably high levels of tolerance.
Although methadone is included in this class, people properly supervised in a
methadone maintenance program should not develop any of the Opioid-induced
Organic Mental Disorders. When the criteria for one of these diagnoses are met, this
indicates that there has been nonmedical use of methadone, in which case the appro-
priate diagnosis should be made.
Patterns of use. There are two patterns of development of dependence and abuse.
In one, which is relatively infrequent, the person originally obtained an opioid by
prescription, from a physician, for the treatment of pain or cough-suppression, but has
gradually increased the dose and frequency of use on his or her own. The person
continues to justify the substance use on the basis of treatment of symptoms, but
substance-seeking behavior becomes prominent, and the person may go to several
physicians in order to obtain sufficient supplies of the substance.
A second pattem that leads to dependence or abuse involves young people in
their teens or early 20s who, with a group of peers, use opioids obtained from illegal
sources. Some use an opioid alone to obtain a "high," or euphoria. Others use these
substances in combination with amphetamines, cannabis, hallucinogens, or sedatives
to enhance the euphoria or to counteract the depressant effect of the opioid. In this
I
